Jotin Marango - Apr 25, 2022 Form 3 Insider Report for Ikena Oncology, Inc. (IKNA)

Role
CFO & Head of Corp. Dev.
Signature
/s/ Jotin Marango
Stock symbol
IKNA
Transactions as of
Apr 25, 2022
Transactions value $
$0
Form type
3
Date filed
4/25/2022, 06:48 PM
Previous filing
Jan 20, 2022
Next filing
Jan 5, 2023

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney